Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 9, 2006

Source MDx Initiates RA Collaboration and Receives RA Grant

  • Tufts-New England Medical Center (NEMC) and Source MDx will collaborate to develop a molecular diagnostic test for rheumatoid arthritis. Researchers at Tufts-NEMC, led by co-principal investigator, Tim McAlindon, M.D., chief of rheumatology at Tufts-NEMC, will manage the clinical studies for a molecular diagnostic test that will characterize rheumatoid arthritis patients and their response to anti-TNF therapy.

    Source MDx will provide gene expression analysis of whole blood samples from the approximately 100 participating patient population based on its RA Precision Profile™ gene panel designed to diagnose and monitor RA patients and its Healthy Normals Reference dataset.

    In conjunction with the Tufts-NEMC study, Source MDx was awarded an SBIR grant by the NIH to initiate the development of a molecular diagnostic test using biomarkers to predict responders and non responders to antitumor neurosis factor therapy for rheumatoid arthritis. The grant provides over $195,000 in funding over a one-year period.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »